Lets Start Screening For Breast Health

Home
>
Breast Cancer
>
Lets Start Screening For Breast Health

Lets Start Screening For Breast Health

In the United States, American women are told to begin annual mammographic screening for breast cancer at the age of 40. Long before we've reached this age, we are advised to perform a monthly breast exam and see our doctors for a clinical breast exam (CBE) annually as well. However, the detection rate of breast cancer for CBE is only 47% when the tumors are less than 1 centimeter while mammography has given us a 70% detection rate. By the time a tumor is detected by palpation or found mammographically, it has already been growing and developing for 8-10 years.

Mammography has a high false positive rate. Only 1:6 biopsies are found to be positive for cancer when performed due to a positive mammogram or CBE. This places additional stressors on women who undergo these procedures.

Other risks of mammography include the radiation that each breast is exposed to during a mammogram. During a chest X-ray, a person receives 1/1000 of a RAD, or radiation absorbed dose. This type of X-ray is a high energy X-ray. During a mammogram, however, the X-ray used is a low energy X-ray and results in 1 RAD or a 1000-fold greater exposure than a simple chest X-ray. It has been suggested that the low energy X-ray used may cause greater biological damage which is cumulative over time. In a journal entitled Radiation Research and published in 2004, the author concludes that the risks associated with mammography screening may be FIVE times higher than previously assumed and the risk-benefit relationship of mammography exposures need to be re-examined.

In 1982, the FDA approved thermography as an adjunctive tool for breast cancer screening. Digital Infrared Thermal Imaging, also known as DITI measures heat emitted from the body and is accurate to 1/100th of a degree. Certified Clinical Thermographers follow strict guidelines and transmit their scans for interpretation by board certified thermologists. DITI examines physiology, NOT structure. It is in this capacity that DITI can monitor breast HEALTH over time and alert a patient or physician to a developing problem; possibly before a lump can be seen on X-ray or palpated clinically. There are no test limitations such as breast density. Women with cosmetic implants are great candidates for thermography which emits no radiation and no compression. Contact is never made during a thermographic scan.

Clinical research studies continue to support thermography's role as an adjunctive tool in breast cancer screening and the ONLY tool that measures breast health. There are now more than 800 publications on over 300,000 women in clinical trials. A recent finding published in the American Journal of Radiology in 2003 showed that thermography has 99% sensitivity in identifying breast cancer with single examinations and limited views. Scientists concluded that a negative thermogram is powerful evidence that cancer is not present.

In conclusion, women need to begin breast health screening early; as young as age 25. This can provide women with the earliest possible indication that further investigation is necessary. It takes approximately 15 years for a breast cancer to form and lead to death. If "early detection is the best prevention," let's start using technology that truly allows for the earliest possible alert to a developing problem.

Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com.

Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She is an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area.

In The News:

Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening
MarketWatch (press release)
According to a publication funded by the Susan G. Komen Foundation, 1.6 million women worldwide were diagnosed with breast cancer in 2010 and 425000 women died from the disease. Although early detection is the best means to a good prognosis for breast ...

and more »

Al-Arabiya
Rusty Link: The Lackluster Science Behind the Abortion–Breast Cancer Connection
Slate Magazine
Now, providers there must inform pregnant women about “the possibility of increased risk of breast cancer following an induced abortion,” the so-called ABC link. In the decade following Roe v. Wade, the occurrence of breast tumors in the United States ...
Saudi women take fight against breast cancer to Mount EverestAl-Arabiya
Breast cancer advocacy organizations target the under 45 patientThe Imperfect Parent
A woman's journey: destination Mount EverestPakistan Daily Times
New Zealand Herald -The Voice of Russia -HealthTechZone
all 12 news articles »

Jagran Post
Moderate Weight Loss Can Decrease Breast Cancer Risk
ABC News
Could moderate weight loss lower your chance of developing breast cancer? Researchers from the Fred Hutchinson Cancer Research Center think it's possible. The connection between obesity and breast cancer risk in women after menopause has long been ...
Dropping a Few Pounds Could Lower Breast Cancer RiskTIME
Small weight loss effectively reduces sex hormones linked with breast cancerFox News
Dieting May Lower Hormone Levels Tied to Breast CancerU.S. News & World Report
Jagran Post -Globe and Mail -Seattle Post Intelligencer
all 54 news articles »

ABC15.com (KNXV-TV)
Questions about Valley breast cancer charity, where donation money is really used
ABC15.com (KNXV-TV)
When Pat Elliot of Phoenix received what she called an "aggressive" call from a telemarketer representing The Breast Cancer Society, Inc., she was concerned. “It does not appear that patients with breast cancer are being served,” she said.

and more »

Firstpost
New breast cancer test to predict return of tumour post surgery
Daily News & Analysis
A breast cancer test that could spare thousands of women the ordeal of chemotherapy could be available in the UK this year. The test costs just £120 a time and can accurately predict whether a tumour is likely to return after it has been surgically ...
Now, a breast cancer test to predict if tumour will recurBusiness Standard
Find out cheap if breast cancer tumour will returnFirstpost

all 10 news articles »

Galena Biopharma's Breast Cancer Vaccine Sprouts More Red Flags
TheStreet.com
By Adam Feuerstein 05/22/12 - 02:23 PM EDT LAKE OSWEGO, Oregon (TheStreet) -- More red flags have been found staked into Galena Biopharma's(GALE) breast cancer vaccine NeuVax. Updated, 60-month follow-up results from a Neuvax phase II study scheduled ...
Galena Biopharma With Near Term ASCO CatalystSeeking Alpha

all 2 news articles »

Breast cancer clinical trial tests combo of heat shock protein inhibitor and ...
Medical Xpress
Researchers have theorized that inhibiting HSP90 just might render breast cancer cells less likely to escape the challenge posed by cutting off their ability to use estrogen. Such is the rationale for a new clinical trial that has begun enrolling ...

and more »

Breast MRI helps predict chemotherapy's effectiveness
Medical Xpress
Women with breast cancer often undergo chemotherapy prior to surgery. Research has shown that women who receive this treatment, known as neoadjuvant chemotherapy, are more likely to achieve breast conservation than those receiving chemotherapy after ...
Breast MRI and Chemo EffectivenessIvanhoe

all 5 news articles »

Keeping breast cancer at bay: Doctors from China train at CentraState
News Transcript
PHOTO COURTESY OF CENTRASTATE MEDICAL CENTER Seven physicians from China traveled to New Jersey recently to learn about the latest imaging and interventional techniques to diagnose breast cancer as early as possible. From April 30 to May 5, ...

Sydney Morning Herald
Benefits of Hormone-Replacement Therapy Outweigh Risks, Reviews of Studies Show
Wall Street Journal (blog)
Much of that big government study was halted in July 2002 after data suggested that women taking estrogen-and-progestin replacement had a higher rate of heart disease, stroke and breast cancer than those on a placebo. Millions of women and their ...
Doctors rethink hormone therapySydney Morning Herald
Call for 'rational use' of hormone therapy near menopauseNew Zealand Herald
The rollercoaster ride of menopauseFond du Lac Reporter
WebMD.Boots.com -Telegraph.co.uk
all 191 news articles »

Google News